Inicio

Investigación e Informes

Informes técnicos, estudios y datos de mercado

Investigación e Informes
6 sept 2026•1 min de lectura
Study suggests combining potassium increase with sodium reduction improves hypertension control
A recent report in The American Journal of Clinical Nutrition argues that adding potassium to sodium‑reduction diets may better manage high blood pressure.
Investigación e Informes
6 sept 2026•1 min de lectura
Pharmacists urged to guide patients on AI-driven digital health tools
AI tools are expanding, and a pharmacy professor highlights pharmacists' role in interpreting digital health data and advising when clinical care is needed.
Investigación e Informes
6 sept 2026•1 min de lectura
Boehringer Ingelheim halts Phase 1 trial of oral small molecule BI 3031185 over safety event
Boehringer Ingelheim stopped the Phase 1 study of its oral small‑molecule candidate BI 3031185 after a safety event, without revealing details. The trial began in early July in Fukuoka, Japan.
Investigación e Informes
5 sept 2026•1 min de lectura
Rhodiola rosea (홍경천) – Adaptogen with Rosavin and Salidroside
Rhodiola rosea, a high‑altitude plant used traditionally for fatigue and stress, contains the adaptogenic compounds rosavin and salidroside.
Investigación e Informes
5 sept 2026•1 min de lectura
Chronic Rhinitis: Prevalence, Classification, and Standard Therapies
Chronic rhinitis affects 10‑40% of people and is divided into allergic and non‑allergic types; treatment typically involves antihistamines, nasal steroids, decongestants, and leukotriene antagonists.
Investigación e Informes
5 sept 2026•1 min de lectura
Parkinson’s Disease: Pathology, Symptoms, and Current Treatment Options
Parkinson’s disease is a neurodegenerative disorder marked by dopamine neuron loss and Lewy bodies, causing motor and non‑motor symptoms; treatment includes dopamine therapy and deep brain stimulation.
Investigación e Informes
5 sept 2026•1 min de lectura
Parkinson’s disease: dopamine therapy limits and emerging non‑motor symptom concerns
Levodopa remains effective for motor symptoms of Parkinson’s disease, but long‑term use brings motor fluctuations and a range of non‑motor issues that heavily impact patients.
Investigación e Informes
5 sept 2026•1 min de lectura
Study Finds 38% of Korean Parkinson's Patients Receive Potentially Inappropriate Medications
Analysis of 2014‑2019 health‑insurance claims shows 38.3% of patients 40+ with Parkinson’s disease were prescribed an average of 2.61 potentially inappropriate meds, 11% of which could worsen symptoms.
Investigación e Informes
5 sept 2026•1 min de lectura
Pharmacies Use Claude Design to Create AI‑Powered Patient Brochures
Pharmacies find standard pharma pamphlets insufficient and use Claude Design to convert AI‑gathered content into printable A4 brochures.
Investigación e Informes
5 sept 2026•1 min de lectura
Study Finds Depression Impairs Hippocampal Neurogenesis Process
Research from Columbia University and NY State Psychiatric Institute shows that major depressive disorder blocks the transition of stem cells to new neurons in the hippocampus, linking depression to memory and emotional regulation changes.
Investigación e Informes
5 sept 2026•1 min de lectura
Medication errors in Korean pharmacies focus on patients 65+
Pharmacy reports show medication errors, especially leftover drugs and dosing mistakes, are concentrated among patients aged 65 and older, highlighting the need for targeted medication management.
Investigación e Informes
4 sept 2026•1 min de lectura
M2Cloud to Provide ColdCare IoT Service for Moderna's mRNA Vaccine Storage
M2Cloud signed a contract with Moderna to supply its ColdCare cold‑chain IoT service for COVID‑19 vaccine storage and thawing, with on‑site verification completed.